Irfan I Galaria
Overview
Explore the profile of Irfan I Galaria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen A, Albertini J, Bordeaux J, Chen M, Cook J, Davidson C, et al.
Dermatol Surg
. 2021 Jul;
47(7):891-907.
PMID: 34228675
A multi-disciplinary work group involving stakeholders from various backgrounds and societies was convened to develop guidelines for the management of reconstruction after skin cancer resection. The goal was to identify...
2.
Chen A, Albertini J, Bordeaux J, Chen M, Cook J, Davidson C, et al.
J Am Acad Dermatol
. 2021 May;
85(2):423-441.
PMID: 33931288
A multi-disciplinary work group involving stakeholders from various backgrounds and societies was convened to develop guidelines for the management of reconstruction after skin cancer resection. The goal was to identify...
3.
Chen A, Albertini J, Bordeaux J, Chen M, Cook J, Davidson C, et al.
Plast Reconstr Surg
. 2021 Apr;
147(5):812e-829e.
PMID: 33890904
A multi-disciplinary work group involving stakeholders from various backgrounds and societies was convened to develop guidelines for the management of reconstruction after skin cancer resection. The goal was to identify...
4.
White R, Meoli D, Swarthout R, Kallop D, Galaria I, Harvey J, et al.
Am J Physiol Lung Cell Mol Physiol
. 2007 Jun;
293(3):L583-90.
PMID: 17586694
Severe pulmonary arterial hypertension (PAH) occurs in idiopathic form and in association with diverse diseases. The pathological hallmarks are distal smooth muscle hypertrophy, obliteration of small pulmonary arteriole lumens, and...
5.
Bakken A, Galaria I, Agerstrand C, Saad W, Surowiec S, Singh M, et al.
Ann Vasc Surg
. 2007 May;
21(4):474-80.
PMID: 17499964
The role of endovascular therapy for thrombosed dialysis access has grown despite the paucity of data on its viability. The purpose of this study was to characterize the outcomes of...
6.
White R, Galaria I, Harvey J, Blaxall B, Cool C, Taubman M
Chest
. 2005 Dec;
128(6 Suppl):612S-613S.
PMID: 16373864
No abstract available.
7.
Galaria I, Surowiec S, Rhodes J, Shortell C, Illig K, Davies M
Ann Vasc Surg
. 2005 Oct;
19(6):787-92.
PMID: 16228807
Although the long-term (>30 days) effects of endoluminal treatment of superficial femoral artery (SFA) disease have been well studied, the implications of early (< or =30 days) failure are still...
8.
Galaria I, Surowiec S, Tanski W, Fegley A, Rhodes J, Illig K, et al.
Vasc Endovascular Surg
. 2005 Sep;
39(5):393-400.
PMID: 16193211
Modern therapy, including endoluminal procedures and improved medical management, still yield less than desired results for tibial vessel occlusive disease. Despite the recent focus on these newer interventions, few modern...
9.
Roztocil E, Nicholl S, Galaria I, Davies M
Surgery
. 2005 Sep;
138(2):180-6.
PMID: 16153425
Background: Plasminogen activators are used routinely for thrombolysis. They lead to the generation of the protease, plasmin, which can induce smooth muscle cell proliferation and may thus promote further intimal...
10.
Galaria I, Nicholl S, Roztocil E, Davies M
J Surg Res
. 2005 Jun;
127(1):46-52.
PMID: 15964303
Objective: To examine the role of the phospho-inositol-3'-kinase (PI3-K)-akt signaling axis during smooth muscle cell (SMC) migration in response to the aminoterminal fragment of urokinase (ATF). Background: Urokinase (uPA) is...